224 related articles for article (PubMed ID: 21487409)
1. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis.
Bernatsky S; Ramsey-Goldman R; Foulkes WD; Gordon C; Clarke AE
Br J Cancer; 2011 Apr; 104(9):1478-81. PubMed ID: 21487409
[TBL] [Abstract][Full Text] [Related]
2. Cancer risk in systemic lupus: an updated international multi-centre cohort study.
Bernatsky S; Ramsey-Goldman R; Labrecque J; Joseph L; Boivin JF; Petri M; Zoma A; Manzi S; Urowitz MB; Gladman D; Fortin PR; Ginzler E; Yelin E; Bae SC; Wallace DJ; Edworthy S; Jacobsen S; Gordon C; Dooley MA; Peschken CA; Hanly JG; Alarcón GS; Nived O; Ruiz-Irastorza G; Isenberg D; Rahman A; Witte T; Aranow C; Kamen DL; Steinsson K; Askanase A; Barr S; Criswell LA; Sturfelt G; Patel NM; Senécal JL; Zummer M; Pope JE; Ensworth S; El-Gabalawy H; McCarthy T; Dreyer L; Sibley J; St Pierre Y; Clarke AE
J Autoimmun; 2013 May; 42():130-5. PubMed ID: 23410586
[TBL] [Abstract][Full Text] [Related]
3. Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies.
Pfeiffer RM; Park Y; Kreimer AR; Lacey JV; Pee D; Greenlee RT; Buys SS; Hollenbeck A; Rosner B; Gail MH; Hartge P
PLoS Med; 2013; 10(7):e1001492. PubMed ID: 23935463
[TBL] [Abstract][Full Text] [Related]
4. No association between the risk of breast cancer and systemic lupus erythematosus: evidence from a meta-analysis.
Rezaieyazdi Z; Tabaei S; Ravanshad Y; Akhtari J; Mehrad-Majd H
Clin Rheumatol; 2018 Jun; 37(6):1511-1519. PubMed ID: 29294194
[TBL] [Abstract][Full Text] [Related]
5. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
6. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
7. Association of systemic lupus erythematosus autoantibody diversity with breast cancer protection.
Shah AA; Igusa T; Goldman D; Li J; Casciola-Rosen L; Rosen A; Petri M
Arthritis Res Ther; 2021 Feb; 23(1):64. PubMed ID: 33632283
[TBL] [Abstract][Full Text] [Related]
8. Dietary cadmium exposure and risk of breast, endometrial, and ovarian cancer in the Women's Health Initiative.
Adams SV; Quraishi SM; Shafer MM; Passarelli MN; Freney EP; Chlebowski RT; Luo J; Meliker JR; Mu L; Neuhouser ML; Newcomb PA
Environ Health Perspect; 2014 Jun; 122(6):594-600. PubMed ID: 24633137
[TBL] [Abstract][Full Text] [Related]
9. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis.
Ni J; Qiu LJ; Hu LF; Cen H; Zhang M; Wen PF; Wang XS; Pan HF; Ye DQ
Lupus; 2014 Mar; 23(3):284-92. PubMed ID: 24429300
[TBL] [Abstract][Full Text] [Related]
10. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
11. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Cancers of Female Organs among Patients with Diabetes Type 2 in Kelantan, Malaysia: Observations over an 11 Year Period and Strategies to Reduce the Incidence.
Jalil NA; Zin AA; Othman NH
Asian Pac J Cancer Prev; 2015; 16(16):7267-70. PubMed ID: 26514522
[TBL] [Abstract][Full Text] [Related]
13. Sugar-containing beverages and their association with risk of breast, endometrial, ovarian and colorectal cancers among Canadian women.
Arthur RS; Kirsh VA; Mossavar-Rahmani Y; Xue X; Rohan TE
Cancer Epidemiol; 2021 Feb; 70():101855. PubMed ID: 33220638
[TBL] [Abstract][Full Text] [Related]
14. Dietary acrylamide intake and risk of women's cancers: a systematic review and meta-analysis of prospective cohort studies.
Benisi-Kohansal S; Salari-Moghaddam A; Seyed Rohani Z; Esmaillzadeh A
Br J Nutr; 2021 Nov; 126(9):1355-1363. PubMed ID: 33413725
[TBL] [Abstract][Full Text] [Related]
15. Familial Ovarian Cancer Clusters with Other Cancers.
Zheng G; Yu H; Kanerva A; Försti A; Sundquist K; Hemminki K
Sci Rep; 2018 Aug; 8(1):11561. PubMed ID: 30069056
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Gordon C; Clarke AE
Int J Cancer; 2011 Dec; 129(12):2966-9. PubMed ID: 21448902
[TBL] [Abstract][Full Text] [Related]
17. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study.
Gottschau M; Kjaer SK; Jensen A; Munk C; Mellemkjaer L
Gynecol Oncol; 2015 Jan; 136(1):99-103. PubMed ID: 25451694
[TBL] [Abstract][Full Text] [Related]
18. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
Petitti DB; Porterfield D
Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
[TBL] [Abstract][Full Text] [Related]
19. Modification of the Associations Between Duration of Oral Contraceptive Use and Ovarian, Endometrial, Breast, and Colorectal Cancers.
Michels KA; Pfeiffer RM; Brinton LA; Trabert B
JAMA Oncol; 2018 Apr; 4(4):516-521. PubMed ID: 29346467
[TBL] [Abstract][Full Text] [Related]
20. Reduced risk of breast, endometrial and ovarian cancer in women with celiac disease.
Ludvigsson JF; West J; Ekbom A; Stephansson O
Int J Cancer; 2012 Aug; 131(3):E244-50. PubMed ID: 21953605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
